deoxycytidine and Bilateral Headache

deoxycytidine has been researched along with Bilateral Headache in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (75.00)	29.6817
2010's	1 (25.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Andrade-Villanueva, J; Callebaut, C; Cao, H; Cheng, AK; Crofoot, G; Custodio, JM; DeJesus, E; Fordyce, MW; Koenig, E; Martin, H; McCallister, S; Molina, JM; Oka, S; Plummer, A; Podzamczer, D; Post, F; Pozniak, A; Saag, M; Sax, PE; Thompson, M; Trottier, B; Wohl, D; Yin, MT; Zhong, L	1
Hansen, SW; Larsen, FO	1
Fakih, MG; Raman, AK	1
Cahn, P; Cassetti, I; Holdich, T; Rolon, M; Sawyer, J; Shiveley, L	1

Trials

2 trial(s) available for deoxycytidine and Bilateral Headache

Article	Year
Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials. Lancet (London, England), 2015, Jun-27, Volume: 385, Issue:9987 Topics: Adenine; Adult; Alanine; Anti-HIV Agents; Arthralgia; Bone Density; Carbamates; CD4 Lymphocyte Count; Cobicistat; Deoxycytidine; Double-Blind Method; Drug Combinations; Emtricitabine; Female; Headache; HIV Infections; Humans; Kidney; Male; Nausea; Organophosphonates; Quinolones; Respiration Disorders; Sleep Initiation and Maintenance Disorders; Tenofovir; Thiazoles; Treatment Outcome; Viral Load	2015
Multiple-dose pharmacokinetics of apricitabine, a novel nucleoside reverse transcriptase inhibitor, in patients with HIV-1 infection. Clinical drug investigation, 2008, Volume: 28, Issue:2 Topics: Administration, Oral; Adult; Amylases; Area Under Curve; Biological Availability; Capsules; CD4 Lymphocyte Count; Deoxycytidine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Half-Life; Headache; HIV Infections; HIV-1; Humans; Nasal Obstruction; Nucleosides; Reverse Transcriptase Inhibitors; Stereoisomerism	2008

Article

Year

Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials.

Lancet (London, England), 2015, Jun-27, Volume: 385, Issue:9987

Topics: Adenine; Adult; Alanine; Anti-HIV Agents; Arthralgia; Bone Density; Carbamates; CD4 Lymphocyte Count; Cobicistat; Deoxycytidine; Double-Blind Method; Drug Combinations; Emtricitabine; Female; Headache; HIV Infections; Humans; Kidney; Male; Nausea; Organophosphonates; Quinolones; Respiration Disorders; Sleep Initiation and Maintenance Disorders; Tenofovir; Thiazoles; Treatment Outcome; Viral Load

2015

Multiple-dose pharmacokinetics of apricitabine, a novel nucleoside reverse transcriptase inhibitor, in patients with HIV-1 infection.

Clinical drug investigation, 2008, Volume: 28, Issue:2

Topics: Administration, Oral; Adult; Amylases; Area Under Curve; Biological Availability; Capsules; CD4 Lymphocyte Count; Deoxycytidine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Half-Life; Headache; HIV Infections; HIV-1; Humans; Nasal Obstruction; Nucleosides; Reverse Transcriptase Inhibitors; Stereoisomerism

2008

Other Studies

2 other study(ies) available for deoxycytidine and Bilateral Headache

Article	Year
Severe neurotoxicity caused by gemcitabine treatment. Acta oncologica (Stockholm, Sweden), 2004, Volume: 43, Issue:6 Topics: Aged; Antimetabolites, Antineoplastic; Central Nervous System Diseases; Confusion; Deoxycytidine; Female; Gemcitabine; Headache; Humans; Lung Neoplasms; Male; Middle Aged; Ovarian Neoplasms; Seizures; Urinary Bladder Neoplasms	2004
Capecitabine-induced headache responding to diltiazem. Chemotherapy, 2007, Volume: 53, Issue:4 Topics: Adult; Antimetabolites, Antineoplastic; Capecitabine; Deoxycytidine; Diltiazem; Female; Fluorouracil; Headache; Humans; Rectal Neoplasms	2007